Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 28 Sept 2026 for Lexeo Therapeutics, Inc., €8,380.
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Narinder Pal Bhalla: trading record in brief
Narinder Pal Bhalla discloses dealings in Lexeo Therapeutics, Inc. to SEC (Form 4). We count 4 filings; the first trade dates from 13 February 2026 and the latest from 14 September 2026.
Every open-market trade on record is a sale: 1 sale worth €87k. The rest of the record consists of 3 share grants.
The newest entry dates from 28 September 2026: a share grant of €8,380, in Lexeo Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Narinder Pal Bhalla
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
2,714 shares@ US$3.579Common StockSEC:0002109299-26-000009:0
55,000 sharesCommon StockSEC:0002109299-26-000007:0
22,306 sharesCommon StockSEC:0002109299-26-000007:1
49,500 shares0Common StockSEC:0002109299-26-000004:0
4 of 4 declarations
